p63 expression as a new prognostic marker in Merkel cell carcinoma

Sofia Asioli1, Alberto Righi, Marco Volante

  • 1Department of Biomedical Sciences and Human Oncology, University of Turin, Italy. sofia.asioli@unito.it

Cancer
|June 30, 2007
PubMed
Summary

p63 expression is a new prognostic marker for Merkel cell carcinoma (MCC), an aggressive skin cancer. Positive p63 indicates a worse clinical outcome, aiding in patient management.